Among the CSF biomarkers evaluated, NfL (followed by YKL40, GFAP, Aβ42, pTau, and tTau) had the greatest diagnostic value for discriminating CU A− individuals from patients with MCI or AD-dementia. Here, GFAP is linked to Alzheimer disease.